The new codes are for describing the infusion of tixagevimab and cilgavimab monoclonal antibody (code XW023X7), and the infusion of other new technology monoclonal antibody (code XW023Y7).
Search the full ICD-10 catalog by:
The ICD-10-CM is a catalog of diagnosis codes used by medical professionals for medical coding and reporting in health care settings. The Centers for Medicare and Medicaid Services (CMS) maintain the catalog in the U.S. releasing yearly updates.
N85. 00 - Endometrial hyperplasia, unspecified | ICD-10-CM.
621.33 - Endometrial hyperplasia with atypia. ICD-10-CM.
ICD-10 code N85. 00 for Endometrial hyperplasia, unspecified is a medical classification as listed by WHO under the range - Diseases of the genitourinary system .
621.31 - Simple endometrial hyperplasia without atypia | ICD-10-CM.
Endometrial hyperplasia is an abnormal proliferation of the uterine endometrial glands due to effects of estrogen unopposed by progesterone. This condition can be benign or represent a precancerous endometrial lesion.
Endometrial Hyperplasia: A condition in which the lining of the uterus grows too thick. Endometrial Intraepithelial Neoplasia (EIN): A precancerous condition in which areas of the lining of the uterus grow too thick.
"Disordered proliferative endometrium" is a somewhat vague term that generally indicates the unusual growth of endometrial cells. The term can refer to a form of simple endometrial hyperplasia — or the abnormal thickening of the endometrial lining — but it can indicate a more serious problem in some cases.
(en-doh-MEE-tree-um) The layer of tissue that lines the uterus.
The endometrium is the inner layer that lines the uterus. It is made up of glandular cells that make secretions.
Atypical hyperplasia is a precancerous condition that affects cells in the breast. Atypical hyperplasia describes an accumulation of abnormal cells in the milk ducts and lobules of the breast. Atypical hyperplasia isn't cancer, but it increases the risk of breast cancer.
Endometrial atrophy is characterized by reduction in the thickness of the endometrium and loss of endometrial glands, which are inconspicuous and embedded in dense compact stroma. The smooth muscle cells show reduced sarcoplasm and myometrium consists of closely packed cells with elongated nuclei and scanty cytoplasm.
The code for endometrial biopsy (58100) specifies “without cervical dilation.” It may not be combined with the code for cervical dilation (57800) because of a CCI edit. The appropriate code to use when the cervix is dilated at the time of endometrial biopsy is 58120 (dilation and curettage).
Benign proliferation of the endometrium in the uterus. Endometrial hyperplasia is classified by its cytology and glandular tissue. There are simple, complex (adenomatous without atypia), and atypical hyperplasia representing also the ascending risk of becoming malignant.
There are four types of endometrial hyperplasia: simple endometrial hyperplasia, complex endometrial hyperplasia, simple endometrial hyperplasia with atypia, and complex endometrial hyperplasia with atypia. These differ in terms of how abnormal the cells are and how likely it is that the condition will become cancer.
A benign condition in which tissue that looks like endometrial tissue grows in abnormal places in the abdomen. A condition in which functional endometrial tissue is present outside the uterus. It is often confined to the pelvis involving the ovary, the ligaments, cul-de-sac, and the uterovesical peritoneum.
It can grow on the ovaries, behind the uterus or on the bowels or bladder. Rarely, it grows in other parts of the body. This "misplaced" tissue can cause pain, infertility, and very heavy periods.